Skip to main content
Top
Published in: La radiologia medica 3/2019

01-03-2019 | RADIOTHERAPY

Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis

Authors: Alba Fiorentino, Rosario Mazzola, Valentina Lancellotta, Simonetta Saldi, Sara Chierchini, Anna Rita Alitto, Paolo Borghetti, Fabiana Gregucci, Michele Fiore, Isacco Desideri, Lorenza Marino, Daniela Greto, Giovanni Domenico Tebala, AIRO Giovani - Italian Association of Radiation Oncology-Young Members Working Group

Published in: La radiologia medica | Issue 3/2019

Login to get access

Abstract

Aim

The difficulty in conducting meaningful clinical research is a multifactorial issue, involving political, financial and cultural problems, which can lead to unexpected negative long-term consequences, in terms of knowledge advancement and impact on patient care. The aims of the present review were to evaluate the publications of Italian radiotherapy (RT) groups during a 20-year period and to verify whether research is still appealing to young radiation oncologists (ROs) in Italy.

Methods

PubMed database was searched for English-language articles published by Italian groups from January 1985 to December 2005. Analyzed variables were: publication/year, kind of study, geographical area and age of the first author.

Results

The systematic review identified 3291 articles: 1207 papers fulfilled the inclusion criteria. The number of Italian published papers increased during the examined period. Retrospective analyses, prospective phase I–II trials and literature reviews were 44, 20 and 14.5% of all published manuscripts, respectively. Randomized trials showed a mild increase from 2000 to 2005, but their absolute number remained low respect to other types of studies (4%). Northern Italy produced the very most of Italian research papers (58.7%). The age of the first/second author was evaluated on 716 papers: In more than 50% of cases, the first author was younger than 40.

Conclusion

Despite a general gradual improvement, RT clinical research suffers in Italy (as elsewhere) from insufficient funding, with a negative impact on evidence production. It is worth noting that clinical research is still appealing and accessible to junior Italian RO.
Literature
2.
3.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009(6):e1000097CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009(6):e1000097CrossRef
4.
go back to reference Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B et al (2015) Expanding global access to radiotherapy. Lancet Oncol 16(10):1153–1186CrossRefPubMed Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B et al (2015) Expanding global access to radiotherapy. Lancet Oncol 16(10):1153–1186CrossRefPubMed
5.
go back to reference Poortmans P, Valentini V, Lievens Y (2015) Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspective. Lancet Oncol. 16(10):1148–1149CrossRefPubMed Poortmans P, Valentini V, Lievens Y (2015) Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspective. Lancet Oncol. 16(10):1148–1149CrossRefPubMed
6.
go back to reference Hanna TP, Shafiq J, Delaney GP, Vinod SK, Thompson SR, Barton MB (2018) The population benefit of evidence-based radiotherapy: 5-year local control and overall survival benefits. Radiother Oncol 126(191–197):10 Hanna TP, Shafiq J, Delaney GP, Vinod SK, Thompson SR, Barton MB (2018) The population benefit of evidence-based radiotherapy: 5-year local control and overall survival benefits. Radiother Oncol 126(191–197):10
7.
go back to reference Valentini V, Bourhis J, Hollywood D (2012) ESTRO 2012 strategy meeting: vision for radiation oncology. Radiother Oncol 103:99–102CrossRefPubMed Valentini V, Bourhis J, Hollywood D (2012) ESTRO 2012 strategy meeting: vision for radiation oncology. Radiother Oncol 103:99–102CrossRefPubMed
8.
go back to reference Kron T, Chesson B, Hardcastle N, Crain M, Clements N, Burns M et al (2018) Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer. Br J Radiol 91(1085):20170737CrossRefPubMedPubMedCentral Kron T, Chesson B, Hardcastle N, Crain M, Clements N, Burns M et al (2018) Credentialing of radiotherapy centres in Australasia for TROG 09.02 (Chisel), a Phase III clinical trial on stereotactic ablative body radiotherapy of early stage lung cancer. Br J Radiol 91(1085):20170737CrossRefPubMedPubMedCentral
9.
go back to reference Martin JM, Rosewall T, Bayley A, Bristow R, Chung P, Crook J et al (2007) Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 69(4):1084–1089CrossRefPubMed Martin JM, Rosewall T, Bayley A, Bristow R, Chung P, Crook J et al (2007) Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 69(4):1084–1089CrossRefPubMed
10.
go back to reference Aggarwal A, Lewison G, Rodin D, Zietman A, Sullivan R, Lievens Y (2018) Radiation therapy research: a global analysis 2001–2015. Int J Radiat Oncol Biol Phys 101(4):767–778CrossRefPubMed Aggarwal A, Lewison G, Rodin D, Zietman A, Sullivan R, Lievens Y (2018) Radiation therapy research: a global analysis 2001–2015. Int J Radiat Oncol Biol Phys 101(4):767–778CrossRefPubMed
11.
go back to reference Schulz KF, Altman DG, Moher D, CONSORT Group (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152(11):726–732CrossRefPubMed Schulz KF, Altman DG, Moher D, CONSORT Group (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152(11):726–732CrossRefPubMed
12.
go back to reference Ioannidis JP, Chang CQ, Lam TK, Schully SD, Khoury MJ (2013) The geometric increase in meta-analyses from China in the genomic era. PLoS ONE 8(6):65602CrossRef Ioannidis JP, Chang CQ, Lam TK, Schully SD, Khoury MJ (2013) The geometric increase in meta-analyses from China in the genomic era. PLoS ONE 8(6):65602CrossRef
14.
go back to reference Poortmans P, Kaidar-Person O, Span P (2017) Radiation oncology enters the era of individualised medicine. Lancet Oncol. 18(2):159–160CrossRefPubMed Poortmans P, Kaidar-Person O, Span P (2017) Radiation oncology enters the era of individualised medicine. Lancet Oncol. 18(2):159–160CrossRefPubMed
16.
go back to reference Franco P, Fiorentino A, Dionisi F, Fiore M, Chiesa S, Vagge S et al (2016) Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting. Tumori 102(5):459–471CrossRefPubMed Franco P, Fiorentino A, Dionisi F, Fiore M, Chiesa S, Vagge S et al (2016) Combined modality therapy for thoracic and head and neck cancers: a review of updated literature based on a consensus meeting. Tumori 102(5):459–471CrossRefPubMed
17.
go back to reference Franco P, De Bari B, Ciammella P, Fiorentino A, Chiesa S, Amelio D et al (2014) The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical set- 11 tings: highlights from the 7th Meeting of AIRO–Young Members Working Group (AIRO Giovani). Tumori 100(6):e214–e219CrossRefPubMed Franco P, De Bari B, Ciammella P, Fiorentino A, Chiesa S, Amelio D et al (2014) The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical set- 11 tings: highlights from the 7th Meeting of AIRO–Young Members Working Group (AIRO Giovani). Tumori 100(6):e214–e219CrossRefPubMed
18.
go back to reference De Bari B, Fiorentino A, Greto D, Ciammella P, Arcangeli S, Avuzzi B et al (2013) Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting. Tumori. 99(6):637–649CrossRefPubMed De Bari B, Fiorentino A, Greto D, Ciammella P, Arcangeli S, Avuzzi B et al (2013) Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting. Tumori. 99(6):637–649CrossRefPubMed
19.
go back to reference Ciammella P, De Bari B, Fiorentino A, Franco P, Cavuto S, Alongi F et al (2013) The “BUONGIORNO” project: burnout syndrome among young Italian radiation oncologists. Cancer Invest 31(8):522–528CrossRefPubMed Ciammella P, De Bari B, Fiorentino A, Franco P, Cavuto S, Alongi F et al (2013) The “BUONGIORNO” project: burnout syndrome among young Italian radiation oncologists. Cancer Invest 31(8):522–528CrossRefPubMed
20.
go back to reference De Bari B, Fiorentino A, Arcangeli S, Franco P, D’Angelillo RM, Alongi F (2014) From radiobiology to technology: what is changing in radiotherapy for prostate cancer. Expert Rev Anticancer Ther 14(5):553–564CrossRefPubMed De Bari B, Fiorentino A, Arcangeli S, Franco P, D’Angelillo RM, Alongi F (2014) From radiobiology to technology: what is changing in radiotherapy for prostate cancer. Expert Rev Anticancer Ther 14(5):553–564CrossRefPubMed
Metadata
Title
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis
Authors
Alba Fiorentino
Rosario Mazzola
Valentina Lancellotta
Simonetta Saldi
Sara Chierchini
Anna Rita Alitto
Paolo Borghetti
Fabiana Gregucci
Michele Fiore
Isacco Desideri
Lorenza Marino
Daniela Greto
Giovanni Domenico Tebala
AIRO Giovani - Italian Association of Radiation Oncology-Young Members Working Group
Publication date
01-03-2019
Publisher
Springer Milan
Published in
La radiologia medica / Issue 3/2019
Print ISSN: 0033-8362
Electronic ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-018-0960-x

Other articles of this Issue 3/2019

La radiologia medica 3/2019 Go to the issue